SynthesisAnnals of hematology2025

Efficacy and safety of venetoclax plus azacitidine based regimens in the treatment of relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.

Qinyi Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.